CLINICAL_TRIALS
trial_result
· 2016-06-02
Clinical Trial Update: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Stage III-IV Chronic Kidney Disease Patients Not on Dialysis With Renal Anemia
Summary
An observational study evaluating Mircera (methoxy polyethylene glycol-epoetin beta) in stage III–IV chronic kidney disease patients not on dialysis with renal …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Anemia | Status: COMPLETED | Results posted: 2016-06-02